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Travelers who have visited tropical areas may exhibit
aggressive forms of obligatory myiases, in which the larvae
(maggots) invasively feed on living tissue. The risk of a
traveler’s acquiring a screwworm infestation has been con-
sidered negligible, but with the increasing popularity of
adventure sports and wildlife travel, this risk may need to
be reassessed. 
Case Report
In November 2001, a 41-year-old Finnish man, who
was participating in an international adventure sports race
in Para (a jungle area in Brazil), tripped at night over a
loose rock while he was riding a bicycle. He received a
bruised, lacerated wound on his left dorsal antebrachium,
which he quickly wiped with paper. The remaining gravel,
dirt, and three unidentified winged insects were removed,
and the wound was thoroughly rinsed 3 hours later by
medical personnel. Petrolatum was applied topically and
the wound bandaged. The patient continued the jungle race
for the next 108 hours, during which the wound was hasti-
ly cleansed and rebandaged twice. The patient repeatedly
swam in the Amazon Basin. At the race’s finish, the wound
appeared purulent and was cleansed with tap water, soap,
and a brush. Numerous attached ticks were removed from
his skin.
The arm became tender, and the patient had bouts of
intensified local pain. A possible, round entry wound,
about 1 mm in diameter, was noted, at the bottom of which
the patient observed motion. Five days after the accident, a
physician explored the wound with scissors at a breakfast
table. No larvae were found. Sugar was applied topically
and cefalexine prescribed. Twenty hours later, the bouts of
pain recurred with increasing frequency. The patient
believed that something left in the wound “ate his flesh.”
Nine days after the accident, at the Frankfurt Airport,
Germany, the patient found a larva (Figure, part B) and an
exit site wound (Figure, part A) under the bandage. The
bouts of tenderness subsided. The patient’s wound was
reexamined 1 day later and was found to be largely healed;
the forming scar remained somewhat tender and itchy for
2 months. The maggot was sent to the Finnish Museum of
Natural History, Helsinki, Finland, and identified as a
third-stage larva of Cochliomyia hominivorax (Coquerel),
the New World screwworm fly. In addition to the New
World screwworm fly, an important Old World species,
Chrysoimya bezziana, is also found in tropical Africa and
Asia.
Conclusions
Myiasis is the infestation of live humans and vertebrate
animals by fly larvae. These feed on a host’s dead or living
tissue and body fluids or on ingested food. In accidental or
facultative wound myiasis, the larvae feed on decaying tis-
sue and do not generally invade the surrounding healthy
tissue (1). Sterile facultative Lucilia larvae have even been
used for wound debridement as “maggot therapy.” Myiasis
is often perceived as harmless if no secondary infections
are contracted. However, the obligatory myiases caused by
more invasive species, like screwworms, may be fatal (2).
The screwworms are capable of penetrating through minor
cracks in the skin, entering body openings, and migrating
from wounds to living tissue. Most often this is initiated
when the flies, attracted by the wounds, lay their eggs in
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Figure. Exit site wound on patient’s arm (A) and a maggot, meas-
uring 16 mm in length, from patient’s wound (B).
A
Bnecrotic, hemorrhagic, or pus-filled lesions. Infestation
and penetration of the ocular, nasopharyngeal, paranasal,
and auricular cavities are frequently described (3). The
female flies colonize the wounds with bacteria like
Providencia spp., which in turn attract more flies by the
distinct odor of the bacterial mass. Secondary bacterial
infections are common. All conditions compromising the
integrity of skin (like tick bites and skin diseases) predis-
pose to the infestation (4). The eggs of Cochliomyia
hominivorax are laid in batches. Hundreds of maggots of
both sexes can be found in a wound. Screwworms can thus
be introduced to new areas by just one index patient.
Considerable risk exists of reintroducing C. hominivorax
into areas from which it has been eradicated. Within 24
hours of hatching, the larvae begin feeding and cause
extensive tissue destruction, pain, and even death. The lar-
vae possess powerful oral hooks and can invade cartilage
and bone (5). After feeding for 4 to 8 days, the larva leaves
the wound to pupate in the soil (6,7). The pest is viable
year round in areas with temperatures constantly >16°C.
C. hominivorax was first found to be infesting people in
the penal colony of Devil’s Island in French Guiana in
1858. It was originally distributed from the southern
United States to Argentina between the 35o north latitude
and the 35o south latitude. Due to a massive sterile male fly
release program,  C. hominivorax was eliminated from
North America. C. hominivorax is an important insect pest
of livestock in the neotropical regions and has caused sub-
stantial losses to the livestock industries of the Americas
(7). It is classified as a restricted animal pathogen in the
United States. At present, populations of C. hominivorax
are found in Central and South America and in certain
Caribbean Islands (4,6,7). Human infestations remain an
important health problem, primarily affecting the severely
debilitated or persons with no access to healthcare. In the
largest published study, the fatality rate was 2.8% (7).
Isolated reports of infestations in the United States and
Mexico are often traced to the importation of infested ani-
mals. Between 1969 and 1988, 39 human cases were
reported (7). The potential for the introduction of C.
hominivorax into new areas is ever present. In 1988, the
screwworm appeared in Libya, most likely imported by
infested livestock. It overwintered and became for the first
time established outside the Western Hemisphere, where it
infected 3,000 livestock and >200 persons. From Tripoli, it
spread rapidly approximately 200 km and threatened to
spread further to the savannas of sub-Saharan Africa. This
possibility presented a potential threat of enormous pro-
portions to the livestock, wildlife, and human populations
of a large part of the Eastern Hemisphere. After a large-
scale campaign, the screwworm was successfully eliminat-
ed from the area in 1991 (7,8). 
In humans, the most common sites of C. hominivorax
infestation are the nose, eyes, and skin. The manifestations
depend on the anatomic region affected but are usually
characterized by local pain, intense pruritus, cutaneous
nodules, and larvae emerging from wounds or cavities
(7,9). Massive infestations can result in the death of the
host, usually attributed to “massive toxic shock” or to pen-
etration of viscera or cavities, especially in the head and
neck area (6,8). Infestation of paranasal sinuses often goes
undetected for long periods. When infestation is suspected,
a careful search for a larval infestation of eyes, nose,
paranasal sinuses, or wounds should be performed, if nec-
essary with the help of computed tomography or magnetic
resonance imaging (7). Radiographic studies may only
show edema. No effective antimicrobial therapy is avail-
able, although doramectin and ivermectin have been inves-
tigated for prophylactic use in cattle. Treatment involves
removal of the larvae (reviewed in [5] and [6]). Irrigation
with either chloroform or ether is advocated. Surgery is
often required. For identification, the larvae should be
hatched to adult flies, or first killed by immersion in near-
ly boiling water, then cooled and preserved in 80%
ethanol. Secondary bacterial infections should be treated
with local wound care and administration of antimicrobial
agents.
In industrialized countries wound myiasis is a sign of
neglected wound care, with mostly facultative myiases
seen. The patients are often debilitated, of lower econom-
ic status, homeless, or substance abusers. The main focus
is in treating secondary bacterial infections and in proper
debridement. The risk of a traveler’s acquiring C.
hominivorax is thought to be negligible (3). With the
increasing popularity of adventure and wildlife travel, the
risk may need to be reassessed. Travelers can contract
aggressive obligatory myiases. This is the third report of C.
hominivorax infestation in a tourist in 3 years (4,9). Also,
a previous case was reported in a U.S. Army ranger who
was wounded in action in Panama (5). In particular, med-
ical personnel who treat patients who have participated in
adventure sports events should recognize the intensity of
the exposure to even the most exotic infectious diseases.
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The International Conference on Women’s
Health and Infectious Diseases, sponsored by the
Centers for Disease Control and Prevention (CDC)
and partners, will be held at the Marriott Marquis,
Atlanta, Georgia, February 27–28, 2004. Intended
for clinicians, scientists, women’s health advocates,
health educators, public health workers, academi-
cians, and representatives from all levels of govern-
ment and from community-based, nonprofit, philan-
thropic, and international organizations, the confer-
ence will promote prevention and control of infec-
tious diseases among women worldwide. 
Featured sessions will include women and
HIV/AIDS, perinatal infectious diseases, immu-
nizations, links between infectious and chronic dis-
eases, and the impact of globalization. Other topics
include infectious disease disparities, gender-appro-
priate interventions, and effective health communi-
cation. 
Speakers will include, Julie L. Gerberding, CDC
director, who will speak about the impact of infec-
tious diseases on women; Carol Bellamy, executive
director, United Nations Children’s Fund
(UNICEF), who will speak about globalization and
its effect on infectious diseases among women; and
Mirta Roses Periago, director, Pan American Health
Organization (PAHO), will speak about prevention
of infectious diseases among women globally. 
International Conference on Women and 
Infectious Diseases: from Science to Action
For information, about cost and registration, contact the Office of Minority and Women’s Health, National Center
for Infectious Diseases, CDC, at Web site: www.womenshealthconf.org; email: omwh@cdc.gov; or phone:
BeJaye Roberts, 404-371-5492.